Study Evaluating Prevenar Immunogenicity in High Risk Children
type: MedicalStudy
description: To Evaluate the Humoral Immune Response to a Conjugated Pneumococcus Vaccine 7-Valent (Prevenar®) in Children From High Risk Groups.
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2002-11
end date: 2007-09
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00581620
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
study subject: Vaccines, Pneumococcal Conjugate Vaccine
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Vaccines, Pneumococcal Conjugate Vaccine

AI Analytics
type: Organization